XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Current Assets      
Cash $ 3,217 $ 93 $ 437
Vendor advances 1,515  
Prepaid expenses and other current assets 10 8
Total Current Assets 4,742 101 437
Deferred offering costs 482 57
Intangible assets, net 262 382 542
Total Other Assets 262 864 599
TOTAL ASSETS 5,004 965 1,036
Current Liabilities      
Accounts payable and accrued expenses 1,530 2,401 1,629
Notes payable - officers     0
Total Current Liabilities 1,672 2,405 1,633
Convertible notes payable, net of debt discount of $105 at December 31, 2023 638 582
Total Liabilities 1,672 3,043 2,215
COMMITMENTS AND CONTINGENCIES - NOTE 7  
Shareholders’ Equity (Deficit)      
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 12,846,785 and 10,562,640 shares issued and outstanding, respectively; 13 11 10
Additional paid-in capital 11,154 4,123 3,211
Accumulated deficit (7,835) (6,212) (4,400)
Total Shareholders’ Equity (Deficit) 3,332 (2,078) (1,179)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) 5,004 965 1,036
Related Party [Member]      
Current Liabilities      
Due to related parties 4 4
Officer [Member]      
Current Liabilities      
Notes payable - officers $ 142
Pro Forma [Member]      
Current Assets      
Cash   93  
Vendor advances    
Prepaid expenses and other current assets   8  
Total Current Assets   101  
Deferred offering costs   482  
Intangible assets, net   382  
Total Other Assets   864  
TOTAL ASSETS   965  
Current Liabilities      
Accounts payable and accrued expenses   1,591  
Total Current Liabilities   1,591  
Convertible notes payable, net of debt discount of $105 at December 31, 2023    
Total Liabilities   1,591  
COMMITMENTS AND CONTINGENCIES - NOTE 7    
Shareholders’ Equity (Deficit)      
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;    
Common stock, par value $0.001, 100,000,000 shares authorized; 12,846,785 and 10,562,640 shares issued and outstanding, respectively;   11  
Additional paid-in capital   5,680  
Accumulated deficit   (6,317)  
Total Shareholders’ Equity (Deficit)   (626)  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)   965  
Pro Forma [Member] | Related Party [Member]      
Current Liabilities      
Due to related parties    
Pro Forma [Member] | Officer [Member]      
Current Liabilities      
Notes payable - officers